Casey L. Daniel

Casey L. Daniel

Auto-generated profile, based on publicly available information

Casey L. Daniel

University of South Alabama, College of Medicine at Mobile, Alabama

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in JCO Oncology Practice
Verified
Journal Article
Closed access
GRGabrielle Rocque
Gabrielle Rocque
DDD’aMbra N. Dent
D’aMbra N. Dent
SIStacey A. Ingram
Stacey A. Ingram
NCNicole E. Caston
Nicole E. Caston
HTHaley B. Thigpen
Haley B. Thigpen
ASAngela Stover
Angela Stover
PURPOSE: Despite evidence of clinical benefits, widespread implementation of remote symptom monitoring has been limited. We describe a process of adapting a remote symptom monitoring intervention developed in a research setting to a real-world clinical setting at two cancer centers. METHODS: This formative evaluation assessed core components and adaptations to improve acceptability and fit of remote symptom monitoring using Stirman's Framework for Modifications and Adaptations. Implementation outcomes were evaluated in pilot studies at the two cancer centers testing technology (phase I) and workflow (phase II and III) using electronic health data; qualitative evaluation with semistructured interviews of clinical team members; and capture of field notes from clinical teams and administrators regarding barriers and recommended adaptations for future implementation. RESULTS: Core components of remote symptom monitoring included electronic delivery of surveys with actionable symptoms, patient education on the intervention, a system to monitor survey compliance in real time, the capacity to generate alerts, training nurses to manage alerts, and identification of personnel responsible for managing symptoms. In the pilot studies, while most patients completed > 50% of expected surveys, adaptations were identified to address barriers related to workflow challenges, patient and clinician access to technology, digital health literacy, survey fatigue, alert fatigue, and data visibility. CONCLUSION: Using an implementation science approach, we facilitated adaptation of remote symptom monitoring interventions from the research setting to clinical practice and identified key areas to promote effective uptake and sustainability.

9 September 2019 in Journal of Cancer Education
Verified
Journal Article
Closed access
PDF file
CDCasey L. Daniel
Casey L. Daniel
LMLane McLendon
Lane McLendon
CGChelsea L. Green
Chelsea L. Green
KAKatie J. Anderson
Katie J. Anderson
JPJennifer Y. Pierce
Jennifer Y. Pierce
MBMark Beasley
Mark Beasley

16 December 2020 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Closed access
LMLane McLendon
Lane McLendon
JPJesse Puckett
Jesse Puckett
CGChelsea Green
Chelsea Green
JJJenna James
Jenna James
KHKatharine J. Head
Katharine J. Head
CDCasey L. Daniel
Casey L. Daniel
Human papillomavirus (HPV) remains the most common sexually transmitted infection (STI) in the U.S. despite widespread availability of a safe, effective vaccine. Although young adults are at greatest risk of HPV infection, extensive vaccine promotion and intervention efforts has been directed toward 11–12-year-olds. College students represent an ideal audience for HPV vaccine “catch-up;” however, research indicates inconsistent HPV vaccination rates within this demographic. An online survey assessing HPV and HPV vaccine knowledge and behaviors was distributed to all undergraduate college students at a large, public university in the Deep South region of the U.S. The primary outcome was receipt of HPV vaccination (binary response options of Yes/No). Logistic regression analyses were performed to determine predictors of HPV vaccination. Of the 1,725 who completed the survey, 47.0% reported having received at least one dose of HPV vaccine; overall series completion (series = 3 doses for this population) was 17.4%. The primary outcome was HPV initiation among college students, defined as having received at least one dose of the HPV vaccine. Results indicated substantial gaps in participants’ knowledge of their vaccination status. Provider and parental recommendations as well as social influences were shown to significantly impact student vaccination status, emphasizing the importance of incorporating these elements in future interventions, potentially as multi-level strategies. Future college interventions should address HPV and vaccination knowledge and the importance of provider and parental recommendations.

1 December 2017 in Preventive Medicine
Verified
Journal Article
Closed access
WGWilliam C. Gambla
William C. Gambla
AFAlyssa M. Fernandez
Alyssa M. Fernandez
NGNatalie R. Gassman
Natalie R. Gassman
MTMarcus C.B. Tan
Marcus C.B. Tan
CDCasey L. Daniel
Casey L. Daniel

29 June 2021 in BMC Public Health
Verified
Journal Article
Open access
PDF file
CDCasey L. Daniel
Casey L. Daniel
FLFrances Lawson
Frances Lawson
MVMacy Vickers
Macy Vickers
CGChelsea Green
Chelsea Green
AWAnna Wright
Anna Wright
STStacie Turberville
Stacie Turberville
Background: Human papillomavirus (HPV) is the most common sexually transmitted infection in the U.S. with over 80 million infected individuals. High-risk strains are associated with 6 different cancers. Although infection is preventable, U.S. vaccination rates remain suboptimal and there are noted disparities between urban and rural communities due to economic barriers, lack of access, and low awareness and education. Methods: The current pilot study sought to overcome these barriers through an interprofessional collaborative enrolling a community pharmacy in a rural, medically underserved Alabama county as a Vaccines for Children (VFC) provider to provide free vaccines to eligible adolescents. Program evaluation was conducted to determine the intervention’s feasibility. Potential efficacy was assessed by analyzing county-level HPV vaccination uptake and completion rates using state immunization registry data. Results: Over the 8-month study, 166 total vaccines were administered to 89 adolescents ages 10–18, including 55 doses of HPV vaccine, 53 doses of Tdap vaccine, 45 doses of meningococcal vaccine, and 13 doses of influenza vaccine. Among these adolescents, mean age was 12.6 years old, and 64 (71.9%) were VFC patients. The pharmacy recorded an increase in total vaccine administration of 158.8%, an increase in prescription revenue of 34.8%, and an increase in total revenue by 24.4% during the course of the study, compared to the previous year. Conclusions: Findings from the current work demonstrate the potential of this strategy and can serve as a blueprint for statewide and national dissemination and implementation to ultimately increase access to vaccination services, increase vaccination rates, and reduce urban-rural vaccine disparities.

13 January 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
Alexis M KoskanAlexis M Koskan
Alexis M Koskan
ILIris E. LoCoco
Iris E. LoCoco
CDCasey L. Daniel
Casey L. Daniel
BTBenjamin S. Teeter
Benjamin S. Teeter
In early 2022 in the U.S., rural adults were the least likely to vaccinate against COVID-19 due to vaccine hesitancy and reduced healthcare access. This study explored the factors influencing rural adults’ COVID-19 vaccine perceptions and their acceptance of pharmacist-administered vaccination. We utilized phone-based semi-structured interviews with 30 adults living in rural regions of one southwestern state and analyzed the data using a team-based thematic analysis approach. Vaccine-willing participants described knowing other people affected by the virus and their desired protection from the virus. They reported trusting scientific institutions and the government to provide safe vaccines. Vaccine-hesitant populations, however, feared that the COVID-19 vaccine development process had been rushed, compromising the safety of these newer vaccines. Although they differed in the news sources they preferred for receiving COVID-19 vaccine information, both vaccine-willing and vaccine-hesitant participants described trusting local authorities, such as healthcare providers and county government officials, to provide accurate COVID-19 vaccine information. Regarding the acceptability of pharmacist-administered COVID-19 vaccinations, all but one participant described their acceptance of this healthcare delivery approach. Future outreach should leverage rural adults’ trust in local sources, including community pharmacists, deemed more convenient access points to healthcare, when addressing vaccine hesitancy.